Emerald Therapeutics, Inc. — Form D
Emerald Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-29. The offering totals $2.9M, of which $1.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2012-03-29
- Form: D
- Accession: 0001501852-12-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $2.9M
- Amount sold: $1.0M
- Remaining: $1.9M
- Investors: 4
- Date of first sale: 2012-03-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-175876
Issuer
- Name: Emerald Therapeutics, Inc.
- CIK: 0001501852
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 3745-M EDISON WAY, MENLO PARK, CA, 94025
- Phone: 650-257-7554
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Brian Frezza | Director | Menlo Park, CA |
| Luke R Nosek | Director | Menlo Park, CA |
| Brian Frezza | Executive Officer | Menlo Park, CA |
| Max R Levchin | Director | San Francisco, CA |
| Daniel J Kleinbaum | Director | Menlo Park, CA |
| Daniel J Kleinbaum | Executive Officer | Menlo Park, CA |
| Brian R Singerman | Director | Menlo Park, CA |
| Brian J Frezza | Director | Menlo Park, CA |
| Brian J Frezza | Executive Officer | Menlo Park, CA |
| Luke J Nosek | Director | San Francisco, CA |
Other filings by this issuer (3)
More